IBM Forecast, price target & analysts
IBM Target price 2025 - Analyst rating & recommendation
IBM Classifications & Recommendation:
IBM Price Target
| Target Price | $265.20 |
| Price | $291.93 |
| Deviation | 9.16% |
| Number of Estimates | 22 |
| 22 Analysts have issued a price target IBM 2026 . The average IBM target price is $265.20. This is 9.16% lower than the current stock price. The highest price target is $336.00 15.10% , the lowest is $171.70 41.18% . | |
| A rating was issued by 27 analysts: 14 Analysts recommend IBM to buy, 10 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the IBM stock has an average upside potential 2026 of 9.16% . Most analysts recommend the IBM stock at Purchase. |
Sales and Margin forecast 2025, 2026 to 2032
23 Analysts have issued a sales forecast IBM 2025 . The average IBM sales estimate is $66.9b . This is 6.47% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $70.1b 11.58% , the lowest is $64.4b 2.43% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $62.8b | 1.44% |
|---|---|---|
| 2025 | $66.9b | 6.60% |
| 2026 | $69.8b | 4.38% |
| 2027 | $72.9b | 4.34% |
| 2028 | $76.3b | 4.75% |
| 2029 | $80.0b | 4.79% |
| 2030 | $82.0b | 2.56% |
| 2031 | $84.7b | 3.33% |
| 2032 | $87.3b | 2.98% |
16 Analysts have issued an IBM EBITDA forecast 2025. The average IBM EBITDA estimate is $18.0b . This is 76.20% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $19.7b 93.40% , the lowest is $16.8b 64.25% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $14.4b | 47.19% |
|---|---|---|
| 2025 | $18.0b | 24.83% |
| 2026 | $19.0b | 5.39% |
| 2027 | $20.0b | 5.63% |
| 2028 | $16.2b | 19.27% |
| 2029 | $17.4b | 7.40% |
EBITDA Margin
| 2024 | 22.95% | 45.10% |
|---|---|---|
| 2025 | 26.88% | 17.11% |
| 2026 | 27.14% | 0.97% |
| 2027 | 27.48% | 1.25% |
24 IBM Analysts have issued a net profit forecast 2025. The average IBM net profit estimate is $10.3b . This is 87.37% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $11.2b 103.77% , the lowest is $9.2b 68.22% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $6.0b | 19.71% |
|---|---|---|
| 2025 | $10.3b | 70.29% |
| 2026 | $10.9b | 6.34% |
| 2027 | $11.5b | 5.70% |
| 2028 | $11.8b | 2.15% |
| 2029 | $13.1b | 11.20% |
| 2030 | $13.9b | 6.09% |
Net Margin
| 2024 | 9.60% | 20.86% |
|---|---|---|
| 2025 | 15.33% | 59.72% |
| 2026 | 15.62% | 1.89% |
| 2027 | 15.82% | 1.28% |
| 2028 | 15.43% | 2.47% |
| 2029 | 16.38% | 6.16% |
| 2030 | 16.94% | 3.42% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
24 Analysts have issued a IBM forecast for earnings per share. The average IBM EPS is $11.04 . This is 90.67% higher than earnings per share in the financial year 2024. The highest EPS forecast is $12.00 107.25% , the lowest is $9.91 71.16% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $6.42 | 21.03% |
|---|---|---|
| 2025 | $11.04 | 71.96% |
| 2026 | $11.74 | 6.34% |
| 2027 | $12.40 | 5.62% |
| 2028 | $12.67 | 2.18% |
| 2029 | $14.09 | 11.21% |
| 2030 | $14.95 | 6.10% |
P/E ratio
| Current | 50.42 | 156.10% |
|---|---|---|
| 2025 | 26.45 | 47.54% |
| 2026 | 24.88 | 5.94% |
| 2027 | 23.54 | 5.39% |
| 2028 | 23.04 | 2.12% |
| 2029 | 20.72 | 10.07% |
| 2030 | 19.53 | 5.74% |
Based on analysts' sales estimates for 2025, the IBM stock is valued at an EV/Sales of 4.74 and an P/S ratio of 4.06 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 5.05 | 57.81% |
|---|---|---|
| 2025 | 4.74 | 6.12% |
| 2026 | 4.54 | 4.19% |
| 2027 | 4.35 | 4.16% |
| 2028 | 4.16 | 4.53% |
| 2029 | 3.97 | 4.57% |
| 2030 | 3.87 | 2.49% |
| 2031 | 3.74 | 3.22% |
| 2032 | 3.63 | 2.89% |
P/S ratio
| Current | 4.32 | 69.19% |
|---|---|---|
| 2025 | 4.06 | 6.07% |
| 2026 | 3.89 | 4.19% |
| 2027 | 3.72 | 4.16% |
| 2028 | 3.56 | 4.53% |
| 2029 | 3.39 | 4.57% |
| 2030 | 3.31 | 2.49% |
| 2031 | 3.20 | 3.22% |
| 2032 | 3.11 | 2.89% |
Current IBM Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Wedbush |
Outperform
➜
Outperform
|
Unchanged | Jun 20 2025 |
| B of A Securities |
Buy
➜
Buy
|
Unchanged | Jun 18 2025 |
| B of A Securities |
Buy
➜
Buy
|
Unchanged | Jun 09 2025 |
| RBC Capital |
Outperform
➜
Outperform
|
Unchanged | May 15 2025 |
| Wedbush |
Outperform
➜
Outperform
|
Unchanged | May 07 2025 |
| UBS |
Sell
➜
Sell
|
Unchanged | Apr 24 2025 |
| Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Apr 24 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Wedbush:
Outperform
➜
Outperform
|
Jun 20 2025 |
|
Unchanged
B of A Securities:
Buy
➜
Buy
|
Jun 18 2025 |
|
Unchanged
B of A Securities:
Buy
➜
Buy
|
Jun 09 2025 |
|
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
May 15 2025 |
|
Unchanged
Wedbush:
Outperform
➜
Outperform
|
May 07 2025 |
|
Unchanged
UBS:
Sell
➜
Sell
|
Apr 24 2025 |
|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Apr 24 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
